Cerebellar purkinje cell dysfunction contributes to gait impairments in Shank3-mutant mice.
Haiying Liu, Xin Huang, Guaiguai Ma and 6 others
PMID 41620607WHAT IT FOUND
In mice with a Shank3 mutation, smaller, less active cerebellar Purkinje cells contributed to abnormal gait.
A virus plus a designer drug activated Purkinje cells and reduced gait deficits in mutant mice; the same approach inhibited Purkinje cells in normal mice and caused gait deficits.
Key findings
01Shank3-mutant mice showed autism-like behaviors and impaired locomotor function, but motor learning on the rotating rod test was not impaired.
02Cerebellar Purkinje cells in Shank3-mutant mice had smaller cell bodies and reduced firing output.
03A virus plus a designer drug activated Purkinje cells and reduced gait deficits in mutant mice; the same approach inhibited Purkinje cells in normal mice and caused gait deficits.
STILL TO COME
How it was doneWhat they foundWhat it means for PTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study was done in mice, not people, so it does not show what helps human gait. Only male mice were studied, so sex differences were not tested. The open-field movement test can be affected by exploration and anxiety, not only motor ability. The rotating rod training period was short and may not fully measure motor learning. The Shank3 deletion affected many cerebellar cell types, so Purkinje cell changes may not be the only cause. Purkinje cell activation or inhibition was partial and did not reverse all gait or social measures.
Declared interests
Funding is listed as Chinese government and provincial research sources. The supplied text does not include an author conflict-of-interest declaration.
The easy way to misread this
Do not read this as evidence that Purkinje cell activation can improve gait in people with autism. The rescue was shown only in male mice with a Shank3 deletion, using a virus and a designer drug, not in human therapy.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →